Five Years Plasma Exchange Experience In Neurological Diseases, Single Center Study
Open Access
- 23 December 2024
- journal article
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Abstract
Therapeutic plasmapheresis exchange (TPE) treatment is used successfully in many neurological diseases. At our center, TPE is used in many neurological cases in addition to various other diseases. In this study, data of patients who underwent TPE between January 2010 and December 2014 were analyzed. In total, 775 sessions, 114 cycles, and 86 patients’ date were evaluated and analyzed. The median age was 49.8 years. 75 patients were followed in the neurology department and 11 patients were followed in the internal medicine intensive care unit. The most common indications for plasmapheresis were myasthenia gravis, multiple sclerosis, and polyneuropathies (respectively, %35, %21, %9.3). In TPE, hypotension developed much less in those using Fresh Frozen Plasma (FFP) as replacement fluid compared to those using albumin [respectively, 2 (%0.9); 25(%4.4)] (pKeywords
This publication has 13 references indexed in Scilit:
- Therapeutic plasma exchange in MS refractory relapses: Long-term outcomeMultiple Sclerosis and Related Disorders, 2021
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueJournal of Clinical Apheresis, 2019
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special IssueJournal of Clinical Apheresis, 2016
- Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: Quantification of the antibody responseJournal of Clinical Apheresis, 2014
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special IssueJournal of Clinical Apheresis, 2013
- Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome, 1996 to 2011 (CME)Transfusion, 2012
- Comparative analysis of therapeutic options used for myasthenia gravisAnnals of Neurology, 2010
- Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for ApheresisJournal of Clinical Apheresis, 2010
- Myasthenia Gravis CrisisSouthern Medical Journal, 2008
- Plasma exchange for generalised myasthenia gravisCochrane Database of Systematic Reviews, 2002